Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-17T17:06:09.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Increased Clostridium difficile Recurrences following Combined Proton Pump Inhibitor–Metronidazole Therapy

Published online by Cambridge University Press:  10 May 2016

Harry W. Daniell
Harry W. Daniell*
Affiliation:
Department of Family Practice, University of California Medical School, Davis, California
*
2626 Edith Avenue, Suite A, Redding, CA 96001 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 1 , January 2014 , pp. 94
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

References

1. Hebert, C, Du, H, Peterson, LR, Robicsek, A. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34:407–414.Google Scholar
2. Al-Nassir, WN, Sethi, AK, Nerandzic, MM, Bobulsky, GS, Jump, RLP, Donskey, CJ. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008;47:56–62.Google Scholar
3. Musher, DM, Logan, N, Mehendiratta, V, Melgarejo, NA, Garud, S, Hamill, RJ. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 2007;59:705–710.Google Scholar